关键词: 同步化放疗, 顺铂, 肺肿瘤, 多西紫杉醇

Abstract: To evaluate the efficacy and side effects of concurrent radiotherapy and chemotherapy with docetaxel/cisplatin for local advanced non-small cell lung cancer (NSCLC). Methods A total of 76 patients with stage Ⅲ NSCLC were randomly divided into two groups: the docetaxel/cisplatin chemotherapy concurrent radiotherapy group(concurrent group) and the docetaxel/cisplatin chemotherapy sequential radiotherapy group(sequential group). In the two groups, the radiation method was the same, five times a week at 2 Gy per day up to a total dose of 60-70Gy. Chemotherapy consisted of docetaxel 40mg/m2 d1，8 and cisplatin 20mg/d, on day 1 and 5, lasting 21 days. The concurrent group received radiotherapy on day 1 of chemotherapy, while the sequential group received radiotherapy after 2 chemotherapy cycles. ResultsThe response rate in the concurrent group was 65.7% and 41.5% in sequential group (P<0.05). The complete response rate was 17.1% in the concurrent group and 7.3% in sequential group (P>0.05). The acute toxic effects such as radiation esophagitis were more severe in the concurrent group than in the sequential group (P<0.05). ConclusionConcurrent radiotherapy and chemotherapy with docetaxel/cisplatin is an effective regimen for advanced nonsmall cell lung cancer with increased but tolerable toxic effects.

Key words: Docetaxel, Cisplatin, Lung neoplasms, Concurrent chemoradiotherapy